Miller Anestesia

78. Suleiman MY, Passannante AN, Onder RL, et al:

Alteration of renal blood flow during epidural anes-

thesia in normal subjects. Anesth Analg 84:1076–

1080, 1997.

79. Halperin BD, Feeley TW: The effect of anesthesia

and surgery on renal function. Int Anesthesiol Clin

22:157–168, 1984.

80. Liu SS, Wu CL: Effect of postoperative analgesia on

major postoperative complications: A systematic

update of the evidence. Anesth Analg 104:689–702,

2007.

81. Moraca RJ, Sheldon DG, Thirlby RC: The role of

epidural anesthesia and analgesia in surgical prac-

tice. Ann Surg 238:663–673, 2003.

82. Oremus K, Safaric Z: The role of epidural anesthesia

and analgesia in surgical practice. Ann Surg 240:

561–562, 2004, author reply 562,.

83. Daudel F, Bone HG, Traber DL, et al: Effects of

thoracic epidural anesthesia on hemodynamics and

global oxygen transport in ovine endotoxemia.

Shock 26:615–619, 2006.

84. Mazze RI: Methoxyflurane revisited: Tale of an

anesthetic from cradle to grave. Anesthesiology

105:843–846, 2006.

85. Mazze RI, Calverley RK, Smith NT: Inorganic fluo-

ride nephrotoxicity: Prolonged enflurane and halo-

thane anesthesia in volunteers. Anesthesiology 46:

265–271, 1977.

86. Cousins MJ, Mazze RI: Methoxyflurane nephrotoxi-

city: A study of dose response in man. JAMA

225:1611–1616, 1973.

87. Mazze RI, Cousins MJ, Kosek JC: Dose-related

methoxyflurane nephrotoxicity in rats: A biochemi-

cal and pathologic correlation. Anesthesiology

36:571–587, 1972.

88. Munday IT, Stoddart PA, Jones RM, et al: Serum

fluoride concentration and urine osmolality after

enflurane and sevoflurane anesthesia in male volun-

teers. Anesth Analg 81:353–359, 1995.

89. Kharasch ED,Armstrong AS, Gunn K, et al: Clinical

sevoflurane metabolism and disposition: II.The role

of cytochrome P450 2E1 in fluoride and hexafluo-

roisopropanol formation. Anesthesiology 82:1379–

1388, 1995.

90. Conzen PF, Nuscheler M, Melotte A, et al: Renal

function and serum fluoride concentrations in

patients with stable renal insufficiency after anes-

thesia with sevoflurane or enflurane. Anesth Analg

81:569–575, 1995.

91. Kharasch ED, Hankins DC, Thummel KE: Human

kidney methoxyflurane and sevoflurane metabo-

lism: Intrarenal fluoride production as a possible

mechanism of methoxyflurane nephrotoxicity.

Anesthesiology 82:689–699, 1995.

92. Malan TP Jr: Sevoflurane and renal function.Anesth

Analg 81:S39–S45, 1995.

93. Frink EJ Jr, Malan TP Jr, Isner RJ, et al: Renal con-

centrating function with prolonged sevoflurane or

enflurane anesthesia in volunteers. Anesthesiology

80:1019–1025, 1994.

94. Morio M, Fujii K, Satoh N, et al: Reaction of sevo-

flurane and its degradation products with soda lime:

Toxicity of the byproducts.Anesthesiology 77:1155–

1164, 1992.

95. Gonsowski CT, Laster MJ, Eger EI, 2nd, et al: Toxi-

city of compound A in rats: Effect of increasing

duration of administration. Anesthesiology 80:566–

573, 1994.

96. Bito H, Ikeuchi Y, Ikeda K: Effects of low-flow sevo-

flurane anesthesia on renal function: Comparison

with high-flow sevoflurane anesthesia and low-flow

isoflurane anesthesia.Anesthesiology 86:1231–1237,

1997.

97. Eger EI, 2nd, Koblin DD, Bowland T, et al: Nephro-

toxicity of sevoflurane versus desflurane anesthesia

in volunteers. Anesth Analg 84:160–168, 1997.

98. Cressey G, Roberts DR, Snowden CP: Renal tubular

injury after infrarenal aortic aneurysm repair. J Car-

diothorac Vasc Anesth 16:290–293, 2002.

99. Kharasch ED, Frink EJ Jr, Zager R, et al: Assessment

of low-flow sevoflurane and isoflurane effects on

renal function using sensitive markers of tubular

toxicity. Anesthesiology 86:1238–1253, 1997.

100. Kharasch ED, Schroeder JL, Liggitt HD, et al: New

insights into the mechanism of methoxyflurane

nephrotoxicity and implications for anesthetic

development. Part 2. Identification of nephrotoxic

metabolites. Anesthesiology 105:737–745, 2006.

101. Julier K, Da Silva R, Garcia C, et al: Preconditioning

by sevoflurane decreases biochemical markers for

myocardial and renal dysfunction in coronary

artery bypass graft surgery: A double-blinded, pla-

cebo-controlled, multicenter study. Anesthesiology

98:1315–1327, 2003.

102. Brezis M, Rosen S, Silva P, Epstein FH: Renal ische-

mia: A new perspective. Kidney Int 26:375–383,

1984.

103. Byrick RJ, Rose DK: Pathophysiology and preven-

tion of acute renal failure: The role of the anaesthe-

tist. Can J Anaesth 37:457–467, 1990.

104. Zimmerhackl B, Robertson CR, Jamison RL: The

microcirculation of the renal medulla. Circ Res

57:657–667, 1985.

105. Zimmerhackl BL, Robertson CR, Jamison RL: The

medullary microcirculation. Kidney Int 31:641–647,

1987.

106. Flamenbaum W: Pathophysiology of acute renal

failure. Arch Intern Med 131:911–928, 1973.

107. Chedru MF, Baethke R, Oken DE: Renal cortical

blood flow and glomerular filtration in myohemog-

lobinuric acute renal failure. Kidney Int 1:232–239,

1972.

108. Knapp R, Hollenberg NK, Busch GJ, Abrams HL:

Prolonged unilateral acute renal failure induced by

intra-arterial norepinephrine infusion in the dog.

Invest Radiol 7:164–173, 1972.

109. Ross B, Freeman D, Chan L: Contributions of

nuclear magnetic resonance to renal biochemistry.

Kidney Int 29:131–141, 1986.

110. Ratcliffe PJ, Moonen CT, Holloway PA, et al: Acute

renal failure in hemorrhagic hypotension: Cellular

energetics and renal function. Kidney Int 30:355–

360, 1986.

111. Ratcliffe PJ, Moonen CT, Ledingham JG, Radda GK:

Timing of the onset of changes in renal energetics

in relation to blood pressure and glomerular filtra-

tion in haemorrhagic hypotension in the rat.

Nephron 51:225–232, 1989.

112. Gamulin Z, Forster A, Morel D, et al: Effects of

infrarenal aortic cross-clamping on renal hemody-

namics in humans. Anesthesiology 61:394–399,

1984.

113. Page US, Washburn T: Using tracking data to find

complications that physicians miss: The case of

renal failure in cardiac surgery. Jt Comm J Qual

Improv 23:511–520, 1997.

114. Ascione R, Nason G, Al-Ruzzeh S, et al: Coronary

revascularization with or without cardiopulmonary

bypass in patients with preoperative nondialysis-

dependent renal insufficiency. Ann Thorac Surg

72:2020–2025, 2001.

115. Loef BG, Epema AH, Navis G, et al: Off-pump coro-

nary revascularization attenuates transient renal

damage compared with on-pump coronary revascu-

larization. Chest 121:1190–1194, 2002.

116. Tang AT, Knott J, Nanson J, et al: A prospective

randomized study to evaluate the renoprotective

action of beating heart coronary surgery in low risk

patients. Eur J Cardiothorac Surg 22:118–123,

2002.

117. Schwann NM, Horrow JC, Strong MD, 3rd, et al:

Does off-pump coronary artery bypass reduce the

incidence of clinically evident renal dysfunction

after multivessel myocardial revascularization?

Anesth Analg 99:959–964, 2004.

118. Gamoso MG, Phillips-Bute B, Landolfo KP, et al:

Off-pump versus on-pump coronary artery bypass

surgery and postoperative renal dysfunction.Anesth

Analg 91:1080–1084, 2000.

119. Hayashida N, Teshima H, Chihara S, et al: Does

off-pump coronary artery bypass grafting really pre-

serve renal function? Circ J 66:921–925, 2002.

120. Sabik JF, Gillinov AM, Blackstone EH, et al: Does

off-pump coronary surgery reduce morbidity and

mortality? J Thorac Cardiovasc Surg 124:698–707,

2002.

121. Karthik S, Musleh G, Grayson AD, et al: Effect of

avoiding cardiopulmonary bypass in non-elective

coronary artery bypass surgery: A propensity score

analysis. Eur J Cardiothorac Surg 24:66–71, 2003.

122. Reston JT, Tregear SJ, Turkelson CM: Meta-analysis

of short-term and mid-term outcomes following

off-pump coronary artery bypass grafting. Ann

Thorac Surg 76:1510–1515, 2003.

123. Al-Ruzzeh S, Ambler G, Asimakopoulos G, et al:

Off-pump coronary artery bypass (OPCAB) surgery

reduces risk-stratified morbidity and mortality: A

United Kingdom multi-center comparative analysis

of early clinical outcome. Circulation 108(Suppl

1):II1–II8, 2003.

124. Cheng DC, Bainbridge D, Martin JE, Novick RJ:

Does off-pump coronary artery bypass reduce mor-

tality, morbidity, and resource utilization when

compared with conventional coronary artery

bypass? A meta-analysis of randomized trials.Anes-

thesiology 102:188–203, 2005.

125. Yates RB, Stafford-Smith M: The genetic determi-

nants of renal impairment following cardiac surgery.

Semin Cardiothorac Vasc Anesth 10:314–326,

2006.

126. Stafford-Smith M, Podgoreanu M, Swaminathan M,

et al: Association of genetic polymorphisms with

risk of renal injury after coronary aftery bypass graft

surgery. Am J Kidney Dis 45:519–530, 2005.

127. Chew ST, Newman MF, White WD, et al: Prelimi-

nary report on the association of apolipoprotein E

polymorphisms, with postoperative peak serum

creatinine concentrations in cardiac surgical

patients. Anesthesiology 93:325–331, 2000.

128. van den Berghe G, Wouters P, Weekers F, et al:

Intensive insulin therapy in the critically ill patients.

N Engl J Med 345:1359–1367, 2001.

129. Stafford-Smith M, Reddan DN, Phillips-Bute B, et

al: Association of perioperative creatinine-derived

variables with mortality and other outcomes after

coronary bypass surgery. Anesth Analg 92:SCA28,

2001.

130. Habib RH, Zacharias A, Schwann TA, et al: Role

of hemodilutional anemia and transfusion during

cardiopulmonary bypass in renal injury after

coronary revascularization: Implications on ope-

rative outcome. Crit Care Med 33:1749–1756,

2005.

131. Altmann D, Zwas D, Spartz AB, et al: Use of the

contrast volume to estimated creatinine clearance

ratio to predict renal failure after angiography.

J Intervent Cardiol 10:113–119, 1997.

132. Perel A, Pizov R, Cotev S: Systolic blood pressure

variation is a sensitive indicator of hypovolemia in

ventilated dogs subjected to graded hemorrhage.

Anesthesiology 67:498–502, 1987.

133. Kilburn KH, Dowell AR: Renal function in respira-

tory failure: Effects of hypoxia, hyperoxia, and

hypercapnia. Arch Intern Med 127:754–762, 1971.

134. Pelletier CL, Shepherd JT: Effect of hypoxia on vas-

cular responses to the carotid baroreflex. Am J

Physiol 228:331–336, 1975.

135. Neylon M, Johns E, Marshall J: The renal response

to systemic hypoxia in the anesthetized rat. J Physiol

(Lond) 452:88P, 1992.

136. Sladen A, Laver MB, Pontoppidan H: Pulmonary

complications and water retention in prolonged

mechanical ventilation. N Engl J Med 279:448–453,

1968.

137. Stafford-Smith M, Grocott HP: Renal medullary

hypoxia during experimental cardiopulmonary

bypass: A pilot study. Perfusion 20:53–58, 2005.

138. Shah D, Corson J, Karmody A, Leather R: Effects of

isovolemic hemodilution on abdominal aortic

aneurysmectomy in high risk patients. Ann Vasc

Surg 1:50–54, 1986.

139. Messmer K: Hemodilution. Surg Clin North Am

55:659–678, 1975.

Monitorización de la función renal

1237

Sección III

Control de la anestesia